Intera Atlas
Run match
Sites / Healthcare Research Network
Is this you?

Request access for Healthcare Research Network with your @healthcareresearchnetwork.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Healthcare Research Network

Unclaimed profile

Site Network · Blue Island, IL (Midwest) · ~Multispecialty network (exact count not specified) sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 5Lift (cardio sample) 0.23Recruit soph 0.29
Quality Scorecard (1–100)
Overall89Recruit74Ops92Sponsor99Ther96

Performance (observed)

Historical trials
800
Completed
415
Terminated/Withdrawn
100
Completion rate
81%
Active now
260
Phase 2
188
Phase 3
493
Realized enrollment
1,109,386
First study year
1994
Years active
32
Match confidence
low (approx)
Enrollment velocity (inf)
34,668

Therapeutic

Areas
Multispecialty (Phase IIB-IV focus)
Specialties
Phase II-IV: Diabetes, GI (Crohn's, IBS, UC, GERD), Rheumatology (RA, Gout), Oncology, Alzheimer's
Breadth (conditions)
1,156
Languages
English + Spanish (detected)
States
Midwest

Recruitment (web observed)

Trial Finder
Yes
Advertises recruitment
Yes
SEO
Y - 1000+ completed studies, established 1998
Capability notes
In-house patient recruitment; access to cutting-edge therapies at no cost to patients

Relationships

Sponsors
Pfizer; National Cancer Institute (NCI); Eli Lilly and Company; Alliance for Clinical Trials in Oncology; Gilead Sciences; Merck Sharp & Dohme LLC
CROs
ICON Clinical Research; IQVIA Pty Ltd; Medpace, Inc.; Microvention-Terumo, Inc.; PPD, Part of Thermo Fisher Scientific; Parexel
Owner / parent
Unknown
Expansion
Y - Multiple Midwest locations (Blue Island IL, Flossmoor IL, Tinley Park IL, Hazelwood MO)

Capacity & people

Investigators
—
Coordinators
—
CEO
Unknown (Jamil Hantash listed as Co-Owner per LinkedIn)
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown

Tech & DCT

eSource
Yes
eConsent
Yes
Builds tech
Unknown
DCT / decentralized
Y - Multiple Midwest locations (IL, MO)
Tech stack
Not mentioned
Recruiting visible
Y

Notes

Established 1998, first in Midwest with Phase IIB-IV standalone multispecialty facilities. 1000+ studies, 100+ sponsors/CROs. Clinician-led. Midwest-only footprint. No visible tech innovation. Weak fit: Small regional network, limited tech, no recruitment marketing, established but stagnant growth signals. [Validated: 10 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 0.32Liftability 0.23Overall89

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.